Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
recombinant equine chorionic gonadotropin analog
- Development stage
- Preclinical
- Lead developer
- Trophogen
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intramuscular, Subcutaneous
01
Overview
Recombinant equine chorionic gonadotropin (eCG) analog is a recombinant protein developed by Trophogen for veterinary use. It is designed to act as a potent agonist of the Luteinizing hormone/choriogonadotropin receptor (LH/CG receptor). In animals, particularly pigs, eCG is utilized to induce and synchronize estrus and ovulation, facilitating controlled breeding programs. This recombinant analog aims to provide a more consistent and purified alternative to traditional serum-derived eCG (pregnant mare serum gonadotropin), which can vary in potency and carry risks of pathogen transmission. The drug is currently in the IND-enabling stage of development.
- Other names
- equine CG analogrecombinant eCGrecombinant equine CG analog
02
Targets
LHCGR (Luteinizing hormone/choriogonadotropin receptor)FSHR (Follicle-stimulating hormone receptor)
Beyond the preview
Go deeper on recombinant equine chorionic gonadotropin analog.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on recombinant equine chorionic gonadotropin analog.